Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP reported 30 positions worth $5.03B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: RVMD (25.4%). Biggest move: exit NUVLEUR ($731.7M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | RVMD | $1.28B | 25.38% | 6,219,323 | — | — | -18.7% | |
| ▸ 2 | GMAB | $504.3M | 10.03% | 14,136,472 | — | — | — | |
| ▸ 3 | EWTX | $437.6M | 8.70% | 10,778,665 | — | — | +7.6% | |
| ▸ 4 | SYRE | $396.8M | 7.89% | 4,457,450 | — | — | +16.8% | |
| ▸ 5 | INSM | $307.7M | 6.12% | 2,695,977 | — | — | +7.7% | |
| ▸ 6 | MBX | $221.2M | 4.40% | 3,772,885 | — | — | -9.4% | |
| ▸ 7 | ORKA | $207.7M | 4.13% | 2,493,507 | — | — | +19.1% | |
| ▸ 8 | BLTE | $194.0M | 3.86% | 1,142,123 | — | — | -4.3% | |
| ▸ 9 | TARS | $180.9M | 3.60% | 2,301,375 | — | — | +2.1% | |
| ▸ 10 | TNGX | $173.7M | 3.45% | 6,961,546 | — | — | -3.1% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Paradigm Biocapital Advisors LP hold as of Q3 2026?
Paradigm Biocapital Advisors LP reported 30 positions worth $5.03B in its Q3 2026 13F filing. Largest positions: RVMD (25.4%), GMAB (10.0%), EWTX (8.7%), SYRE (7.9%) and INSM (6.1%).
What did Paradigm Biocapital Advisors LP buy in Q3 2026?
New positions: BBIO, OBX, GPCR, MANE and ORIC (8 in all). Added to: INSM, MBX, SYRE, JBIO and TYRA (13 in all).
What did Paradigm Biocapital Advisors LP sell in Q3 2026?
Reduced: TARS, RVMD, ERAS, VOR and BLTE (6 in all). Sold out entirely: NUVLEUR, APOGEE THERAPEUTICS INC, ALNY, EYPT and MPLT (6 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.